| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/11/2000 | WO2000025727A2 Use of flumethasone, fluocinolone acetonide fluoromethasone for manufacture of a medicament for the treatment of tumours |
| 05/11/2000 | WO2000025723A2 Methods and compositions for the prevention of tolerance to medications |
| 05/11/2000 | WO2000025721A2 Sodium salt of 3-(4-cinnamyl-1-piperazinyl)imino-methyl rifamycin sv and process of preparation |
| 05/11/2000 | WO2000025697A1 Antimicrobial compositions that protect skin and dental tissue |
| 05/11/2000 | WO2000025665A1 Method for improved imaging and photodynamic therapy |
| 05/11/2000 | WO2000025612A1 Smoking products containing antioxidants |
| 05/11/2000 | WO2000025601A1 Energetic rehydration fluid composition in particular for young animals no longer able to digest milk normally |
| 05/11/2000 | WO2000018381A8 Use of epinastine as antitussivum |
| 05/11/2000 | WO2000013648A8 Method for the preparation of citalopram |
| 05/11/2000 | WO2000013015A8 Modulating multiple lineage kinase proteins |
| 05/11/2000 | WO2000012710A8 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 05/11/2000 | WO2000011968A8 ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID |
| 05/11/2000 | WO2000009691A3 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 05/11/2000 | WO2000009110A3 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| 05/11/2000 | WO2000009099A3 Treatment of vasodilatory headache |
| 05/11/2000 | WO2000008015A3 Fsh mimetics for the treatment of infertility |
| 05/11/2000 | WO2000008007A3 Cyclopentabenzofuran derivatives and their use |
| 05/11/2000 | WO2000007584A3 Method of reducing retinal ganglion cell degeneration |
| 05/11/2000 | WO2000007581A3 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 05/11/2000 | WO2000007578A3 Combination of active substances, especially for the prophylaxis and therapy of ischaemic organic lesions and reperfusion syndromes |
| 05/11/2000 | WO2000007575A3 Methods and compositions for increasing insulin sensitivity |
| 05/11/2000 | WO2000007565A3 Methods of ophthalmic administration |
| 05/11/2000 | WO2000007542A3 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance p |
| 05/11/2000 | WO2000000238A9 Topoisomerase inhibitors for prevention of restenosis |
| 05/11/2000 | WO1999051214A3 Progestogen-only contraceptive kit |
| 05/11/2000 | DE19851758A1 Use of corticosteroids and/or addictive drugs or their pharmacodynamic equivalents to prepare medicaments for treating drug addiction |
| 05/11/2000 | DE19851421A1 Neue Pyrimidine, deren Herstellung und Verwendung New pyrimidines, their preparation and use |
| 05/11/2000 | DE19851375A1 Use of cyclic diazadiazonia-dispiro-alkane derivatives for the treatment and prophylaxis of virus infections, especially herpes and HIV infections |
| 05/11/2000 | DE19851184A1 N-Arylsulfonyl-aminosäure-omega-amide N-arylsulfonyl-amino-omega-amides |
| 05/11/2000 | DE19851126A1 Use of talsaclidine for treating schizophrenia |
| 05/11/2000 | DE19850830A1 Verfahren zur Herstellung einer Lösung, insbesondere einer Dialyse- oder Infusionslösung A process for preparing a solution, in particular dialysis or infusion a solution |
| 05/11/2000 | DE19850790A1 Use of nicotine patch for treating Parkinson's disease |
| 05/11/2000 | DE19850701A1 Benzoylpyridazine Benzoylpyridazine |
| 05/11/2000 | CA2653839A1 Multiparticulate modified release composition |
| 05/11/2000 | CA2640587A1 Gel compositions |
| 05/11/2000 | CA2639619A1 Gel compositions |
| 05/11/2000 | CA2350212A1 Treatment of parkinson's disease with oligonucleotides |
| 05/11/2000 | CA2350052A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
| 05/11/2000 | CA2349567A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 05/11/2000 | CA2349505A1 Nucleic acid constructs for genetic immunization |
| 05/11/2000 | CA2349504A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2349482A1 Pharmaceutical compounds |
| 05/11/2000 | CA2349476A1 Imidazonaphthyridines |
| 05/11/2000 | CA2349444A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 05/11/2000 | CA2349427A1 Method for preventing increased iridial pigmentation during prostaglandin treatment |
| 05/11/2000 | CA2349241A1 Smoking products containing antioxidants |
| 05/11/2000 | CA2349232A1 Benzoylpyridazines |
| 05/11/2000 | CA2348979A1 Method of treating migraines and pharmaceutical compositions |
| 05/11/2000 | CA2348931A1 Dds compound and method for measurement thereof |
| 05/11/2000 | CA2348910A1 Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |
| 05/11/2000 | CA2348907A1 Analgesic regimen |
| 05/11/2000 | CA2348734A1 Thrombin inhibitors |
| 05/11/2000 | CA2348728A1 Method for the production of quercetin and isoquercetin derivatives |
| 05/11/2000 | CA2348714A1 Energetic rehydration fluid composition in particular for young animals no longer able to digest milk normally |
| 05/11/2000 | CA2348703A1 Inhibitors of prenyl-protein transferase |
| 05/11/2000 | CA2348543A1 5ht1 receptor agonists and metoclopramide for the treatment of migraine |
| 05/11/2000 | CA2348536A1 Radiodense compositions |
| 05/11/2000 | CA2348530A1 Thrombin inhibitors |
| 05/11/2000 | CA2348446A1 Benzamide potassium channel inhibitors |
| 05/11/2000 | CA2348392A1 Method for producing luteolin and luteolin derivatives |
| 05/11/2000 | CA2348267A1 Novel inhibitors of impdh enzyme |
| 05/11/2000 | CA2348234A1 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme |
| 05/11/2000 | CA2348094A1 Method for improved imaging and photodynamic therapy |
| 05/11/2000 | CA2347915A1 Enhanced radiation therapy |
| 05/11/2000 | CA2347855A1 Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder |
| 05/11/2000 | CA2347188A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/11/2000 | CA2347098A1 Compositions of and process for producing isotretinoin having low particle size |
| 05/11/2000 | CA2347060A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/11/2000 | CA2346131A1 Method for improving the pharmacokinetics of tipranavir |
| 05/11/2000 | CA2345697A1 Water-miscible pharmaceutical compositions of paclitaxel |
| 05/11/2000 | CA2345337A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 05/11/2000 | CA2317117A1 Ldl related protein and uses thereof |
| 05/11/2000 | CA2312430A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity |
| 05/10/2000 | EP0999220A2 Low molecular weight peptidomimetic growth hormone secretagogues |
| 05/10/2000 | EP0999219A2 Novel heparin binding peptides |
| 05/10/2000 | EP0999212A1 Furopyridine antibacterials |
| 05/10/2000 | EP0999205A1 Aminocycloalkane compounds |
| 05/10/2000 | EP0999204A1 Novel compound having effect of promoting neuron differentiation |
| 05/10/2000 | EP0998945A1 Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy |
| 05/10/2000 | EP0998944A2 Enteric coated formulation of a benzimidazole derivative and method for preparation thereof |
| 05/10/2000 | EP0998939A1 Chalcone plant extracts for use in therapy |
| 05/10/2000 | EP0998937A2 Process for the preparation of a solution, in particular a dialysis or infusion solution |
| 05/10/2000 | EP0998936A1 Substances for the prevention of pathological overexpression of TGF-Beta and methods for evaluating same |
| 05/10/2000 | EP0998934A1 Remedies for intramedullary diseases |
| 05/10/2000 | EP0998933A1 Process for producing pharmaceutical compositions containing diphosphonates for oral administration |
| 05/10/2000 | EP0998932A1 Solid pharmaceutical dosage form containing diphosphonates or their salts and method for its production |
| 05/10/2000 | EP0998931A1 Remedies for dry eye |
| 05/10/2000 | EP0998930A1 Remedial agent for baldness and other diseases |
| 05/10/2000 | EP0998929A2 Topical pharmaceutical compositions for healing wounds comprising borneol and bismuth subgallate |
| 05/10/2000 | EP0998927A1 Absorption-enhancing composition for pantothenic acid derivative |
| 05/10/2000 | EP0998926A1 Oral preparation comprising S-(3-hydroxypropyl)-L-cysteine |
| 05/10/2000 | EP0998925A1 Medicinal compositions for topical administration containing vitamin d and vitamin k |
| 05/10/2000 | EP0998924A1 Antitumor agents |
| 05/10/2000 | EP0998923A1 Use of 5-HT7 receptor agonists for the treatment or prophylaxis of ischemias |
| 05/10/2000 | EP0998920A1 Method for producing solid dosage forms |
| 05/10/2000 | EP0998917A1 Preparation of biodegradable microparticles containing a biologically active agent |
| 05/10/2000 | EP0998916A1 Medicinal compositions for application to mucosa |
| 05/10/2000 | EP0998915A1 Use of silicon gum to stabilize ascorbic acid, and new compositions containing these compounds |
| 05/10/2000 | EP0998914A1 Composition to enhance permeation of topical skin agents |
| 05/10/2000 | EP0998900A1 Use of cholesteric liquid crystal polymers as UV-filters in cosmetic and pharmaceutical preparations |